Classic Risk Factors for Atherosclerosis Are Not Major Determinants for Location of Extracranial or Intracranial Cerebral AtherosclerosisKim Y.D.a · Choi H.Y.a · Jung Y.H.a · Nam C.M.b · Yang J.H.a · Cho H.J.a · Nam H.S.a · Lee K.Y.a · Heo J.H.a
aDepartment of Neurology, National Core Research Center for Nanomedical Technology, and bDepartment of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: The prevalence of extracranial (EC) and intracranial (IC) atherosclerosis varies among races. Although several studies have sought to identify specific vascular risk factors that are associated with EC or IC atherosclerosis, the exact relationships are uncertain. This study aimed to determine if there are any specific risk factors for EC or IC atherosclerosis. Methods: For this study, we considered 3,349 consecutive patients who had been entered into a stroke registry between January 1999 and June 2007. After the exclusion of patients who had not undergone angiography, patients with cardiac sources of embolism or other causes of stroke, and non-Koreans, we had a total of 2,169 patients of single ethnicity with an angiographic analysis. Patients with atherosclerosis in both the IC and EC arteries (856 patients) were excluded. Finally, we identified 1,313 patients who had EC atherosclerosis (EC group, n = 256), IC atherosclerosis (IC group, n = 566) or normal angiographic findings (no-lesion group, n = 488). The frequency of risk factors and the demographic parameters were compared among these groups. Results: When compared to the normal group, the IC group was associated with older age and hypertension, and the EC group was associated with older age, higher initial blood sugar and low-density lipoprotein cholesterol levels. However, in a direct comparison between the IC and EC groups, we did not observe any significant risk factors or variables except for a higher frequency of males and higher total cholesterol levels in the EC group. Conclusions: Vascular risk factors may not be major determinants of location for atherosclerosis in the EC or IC arteries.
© 2009 S. Karger AG, Basel
- Caplan LR, Gorelick PB, Hier DB: Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986;17:648–655.
- Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D: Racial differences in the distribution of anterior circulation occlusive disease. Neurology 1984;34:54–59.
- Nishimaru K, McHenry LC Jr, Toole JF: Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke 1984;15:56–59.
- Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, Caplan LR: Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990;40:1541–1545.
- Suh DC, Lee SH, Kim KR, Park ST, Lim SM, Kim SJ, Choi CG, Lee HK: Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: different involvement of intracranial versus extracranial vessels. AJNR Am J Neuroradiol 2003;24:239–244.
- Solberg LA, McGarry PA: Cerebral atherosclerosis in negroes and Caucasians. Atherosclerosis 1972;16:141–154.
- Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The northern Manhattan stroke study. Stroke 1995;26:14–20.
- Suwanwela NC, Chutinetr A: Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003;22:37–40.
- De Silva DA, Woon FP, Lee MP, Chen CP, Chang HM, Wong MC: South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke 2007;38:2592–2594.
- Weimar C, Goertler M, Harms L, Diener HC: Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol 2006;63:1287–1291.
- Lee BI, Nam HS, Heo JH, Kim DI: Yonsei stroke registry: analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis 2001;12:145–151.
- Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974–1980.
- Bang OY, Lee PH, Yoon SR, Lee MA, Joo IS, Huh K: Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry 2005;76:1128–1134.
- Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI: A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643–646.
- Kitamura A, Iso H, Imano H, Ohira T, Sato S, Naito Y, Iida M, Shimamoto T: Prevalence and correlates of carotid atherosclerosis among elderly Japanese men. Atherosclerosis 2004;172:353–359.
- Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, Huh K: Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005;65:296–298.
- Candelise L, Bianchi F, Galligoni F, Albanese V, Bonelli G, Bozzao L, Inzitari D, Mariani F, Rasura M, Rognoni F, et al: Italian multicenter study on reversible cerebral ischemic attacks. III. Influence of age and risk factors on cerebrovascular atherosclerosis. Stroke 1984;15:379–382.
- Park JH, Kwon HM, Roh JK: Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol 2007;14:379–386.
- Aboyans V, Lacroix P, Criqui MH: Large and small vessel atherosclerosis: similarities and differences. Prog Cardiovasc Dis 2007;50:112–125.
- Malek AM, Alper SL, Izumo S: Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035–2042.
- Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, Smith HH, Nichols F, Rogg J, Cloft HJ, Wechsler L, Saver J, Levine SR, Tegeler C, Adams R, Sloan M: The stroke outcomes and neuroimaging of intracranial atherosclerosis (SONIA) trial. Neurology 2007;68:2099–2106.
- Bash S, Villablanca JP, Jahan R, Duckwiler G, Tillis M, Kidwell C, Saver J, Sayre J: Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005;26:1012–1021.
- Korogi Y, Takahashi M, Nakagawa T, Mabuchi N, Watabe T, Shiokawa Y, Shiga H, O’Uchi T, Miki H, Horikawa Y, Fujiwara S, Furuse M: Intracranial vascular stenosis and occlusion: MR angiographic findings. AJNR Am J Neuroradiol 1997;18:135–143.
- Mayosi BM, Avery PJ, Baker M, Gaukrodger N, Imrie H, Green FR, Farrall M, Watkins H, Keavney B: Genotype at the –174G/C polymorphism of the interleukin-6 gene is associated with common carotid artery intimal-medial thickness: family study and meta- analysis. Stroke 2005;36:2215–2219.
- Zhao J, Cheema FA, Bremner JD, Goldberg J, Su S, Snieder H, Maisano C, Jones L, Javed F, Murrah N, Le NA, Vaccarino V: Heritability of carotid intima-media thickness: a twin study. Atherosclerosis 2008;197:814–820.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.